Research is key to future treatment

The BRC is a partnership between The Royal Marsden and The Institute of Cancer Research, London. It supports innovative translational research, taking leading-edge cancer research from the laboratory and rapidly translating it into a clinical setting.

Latest news

News

A major new study reveals that bowel cancer patients who have become resistant to a widely used targeted treatment could benefit from immunotherapy.

Find out more

News

A new two-in-one drug, which delivers chemotherapy directly to cancer cells, can extend life for women with HER2+ breast cancer known who have stopped responding to other treatments.

Find out more

News

A recent clinical trial has found a pioneering gene-targeted drug designed for breast cancer to be effective in 80 percent of men with BRCA-mutant prostate cancer

Find out more

More information